Trial intelligence / Profile preview

Ascorbic Acid in TRALI (ASTRALI)

NCT04153487Phase 2Completed

Sponsor
Damanhour University
Start
Nov 2019
Primary completion
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ascorbic acid in transfusion-related acute lung injury (TRALI), sponsored by Damanhour University. Started Nov 2019; status: completed.

02

Drugs

ascorbic acid
03

Conditions

transfusion-related acute lung injury (TRALI)

Beyond the preview

Go deeper on NCT04153487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04153487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call